Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs-Reference-Cited by-同舟云学术

Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs

Published:2020-01-17 Issue:1 Volume:9 Page:115-125
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Suzuki Gen^ORCID,Kunikane Eriko,Shinno Keisuke,Kozai Seiko,Kurata Masaaki,Kawamura Akio

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-020-00229-x.pdf

Reference35 articles.

1. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–11.

2. The Japan Glaucoma Society Guidelines for Glaucoma (4th edition). Nihon Ganka Gakkai Zasshi. 2019;122:5–53.

3. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–13.

4. Barnebey HS, Robin AL. Adherence to Fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trial. Am J Ophthalmol. 2017;176:61–9.

5. Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye. 2000;14:752–6.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of Anti-glaucoma Nanofibers as Controlled-Release Inserts for Ophthalmic Delivery of Brimonidine Tartrate: In Vivo Evaluation in Caprine Eye;Advanced Pharmaceutical Bulletin;2024-01-13

2. Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis;Ophthalmology and Therapy;2023-09-07

3. Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study;PLOS ONE;2022-12-01

4. Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy;Expert Review of Clinical Pharmacology;2022-08-03

5. Topical Medication Therapy for Glaucoma and Ocular Hypertension;Frontiers in Pharmacology;2021-12-01